Go offline with the Player FM app!
TWiV 1134: Clinical update with Dr. Daniel Griffin
Manage episode 430924681 series 2652134
In his weekly clinical update, Dr. Griffin discusses Merck’s RSV preventative monoclonal antibody Clesrovimab before reviewing the recent statistics on SARS-CoV-2 infection, if previous SARS-COV-2 infections predict the outcome of subsequent infections, if using COVID rapid diagnostic tests is cost effective, if the protein based vaccine NVX-CoV2327 elicits a durable immune response, if combination treatment of vaccine and antiviral drugs effectively protect against hospitalization, where to find PEMGARDA, what do when healthcare workers succumb to SARS-CoV-2 infection, and how COVID-19 may alter the cognitive trajectories of older patients.
Subscribe (free): Apple Podcasts, Google Podcasts, RSS, emailBecome a patron of TWiV!
Links for this episode- Clesrovimab, RSV preventative monoclonal antibody for infants (Merck)
- COVID-19 national trend (CDC)
- COVID-19 deaths (CDC)
- Characterizing SARS-CoV-2 reinfections and long COVID (Communications Medicine)
- Cost-effectiveness of COVID rapid diagnostic tests (PLoS Medicine)
- NVX-CoV2373 against pre-Delta and Delta strains of COVID-19 little evidence of waning immune response (CID)
- Combined Protection of Vaccination and Nirmatrelvir-Ritonavir Against Hospitalization(CID)
- Pemgarda infusion center locator (Pemgarda)
- Respiratory virus guidance (CDC)
- Early phase of SARS-CoV-2 infection (COVID.gov)
- NIH COVID-19 treatment guidelines (NIH)
- Infectious Disease Society guidelines for treatment and management (ID Society)
- Drug interaction checker (University of Liverpool)
- Molnupiravir safety and efficacy (JMV)
- Convalescent plasma recommendation for immunocompromised (ID Society)
- What do when your heathcare provider is infected with SARS-CoV-2 (CDC)
- Managing healthcare staffing shortages (CDC)
- Steroids,dexamethasone at the right time (OFID)
- Anticoagulation guidelines (hematology.org)
- Cognitive trajectories in older survivors of COVID-19 up to 2.5 years post-infection(Nature Aging)
- Contribute to our Floating Doctors fundraiser
- Letters read on TWiV 1134
- Dr. Griffin’s COVID treatment summary (pdf)
- Timestamps by Jolene. Thanks!
Intro music is by Ronald Jenkees
Send your questions for Dr. Griffin to daniel@microbe.tv
1173 episodes
Manage episode 430924681 series 2652134
In his weekly clinical update, Dr. Griffin discusses Merck’s RSV preventative monoclonal antibody Clesrovimab before reviewing the recent statistics on SARS-CoV-2 infection, if previous SARS-COV-2 infections predict the outcome of subsequent infections, if using COVID rapid diagnostic tests is cost effective, if the protein based vaccine NVX-CoV2327 elicits a durable immune response, if combination treatment of vaccine and antiviral drugs effectively protect against hospitalization, where to find PEMGARDA, what do when healthcare workers succumb to SARS-CoV-2 infection, and how COVID-19 may alter the cognitive trajectories of older patients.
Subscribe (free): Apple Podcasts, Google Podcasts, RSS, emailBecome a patron of TWiV!
Links for this episode- Clesrovimab, RSV preventative monoclonal antibody for infants (Merck)
- COVID-19 national trend (CDC)
- COVID-19 deaths (CDC)
- Characterizing SARS-CoV-2 reinfections and long COVID (Communications Medicine)
- Cost-effectiveness of COVID rapid diagnostic tests (PLoS Medicine)
- NVX-CoV2373 against pre-Delta and Delta strains of COVID-19 little evidence of waning immune response (CID)
- Combined Protection of Vaccination and Nirmatrelvir-Ritonavir Against Hospitalization(CID)
- Pemgarda infusion center locator (Pemgarda)
- Respiratory virus guidance (CDC)
- Early phase of SARS-CoV-2 infection (COVID.gov)
- NIH COVID-19 treatment guidelines (NIH)
- Infectious Disease Society guidelines for treatment and management (ID Society)
- Drug interaction checker (University of Liverpool)
- Molnupiravir safety and efficacy (JMV)
- Convalescent plasma recommendation for immunocompromised (ID Society)
- What do when your heathcare provider is infected with SARS-CoV-2 (CDC)
- Managing healthcare staffing shortages (CDC)
- Steroids,dexamethasone at the right time (OFID)
- Anticoagulation guidelines (hematology.org)
- Cognitive trajectories in older survivors of COVID-19 up to 2.5 years post-infection(Nature Aging)
- Contribute to our Floating Doctors fundraiser
- Letters read on TWiV 1134
- Dr. Griffin’s COVID treatment summary (pdf)
- Timestamps by Jolene. Thanks!
Intro music is by Ronald Jenkees
Send your questions for Dr. Griffin to daniel@microbe.tv
1173 episodes
All episodes
×Welcome to Player FM!
Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.